EXOME

all the information, none of the junk | biotech • healthcare • life sciences

Saver Rate Ends Today for Seattle’s Life Science Disruptors

Xconomy Seattle — 

We’re just a week away from Seattle’s Life Science Disruptors—and we’re offering you the chance to save $80. It all takes place next Monday, May 2, at the Fred Hutchinson Cancer Research Center in Seattle, WA.

Join us to for fireside chats, spotlight talks, keynotes, and more with some of Seattle’s top entrepreneurs, investors, and leaders in the biotech and public health industry.

Our speakers include:
David Baker, Head of the Institute for Protein Design, University of Washington
Aaron Chevalier, CTO, Virvio
Rhea Coler, SVP Preclinical and Translational Research, Infectious Disease Research Institute
Larry Corey, Principal Investigator, HIV Vaccine Trials Network
Jennifer Dent, President, BIO Ventures for Global Health
John Fluke, Chairman, Fluke Capital Management
Stephen Friend, President, Co-founder, & Director, Sage Bionetworks
Rob Hershberg, CSO, Celgene
Leen Kawas, CEO, M3 Biotechnology
Thong Le, CEO, Accelerator
Clayton Lewis, CEO, Arivale
Molly Moore, Assistant Director, Direct Health Solutions Business Development, Cambia Health Solutions
Lucas Nivon, CEO, Cyrus Biotechnology
Nicole Robinson, VP of Industry Relations & Business Development, Fred Hutchinson Cancer Research Center
Andrew Scharenberg, Principal Investigator, Seattle Children’s Research Institute
Ingrid Swanson Pultz, President, PVP Biologics
Jim Thomas, CEO, Just Biotherapeutics
Matthew Trunnell, Chief Information Officer, Fred Hutchinson Cancer Research Center
Cameron Turtle, Immunotherapy researcher and Oncologist, Fred Hutchinson Cancer Research Center
Austin Walsh, Senior State Executive for Washington and Alaska, IBM

Take a look at our agenda to see the sessions and full speaker list. Also, don’t forget to register before midnight to save $80 on regular registration.